Publication: Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells
Loading...
Date
Authors
Aras, Sahra
Özdemir, Beril Su
Palavan Ünsal, Zeynep Narçın
Advisor
item.page.editor
Editor
Department
Journal Title
Journal ISSN
Volume Title
DOI
10.1016/j.jbiotec.2017.06.654
Type
Abstract
Description
Journal or Series
ISSN
0168-1656
